Literature DB >> 10834856

Proposal to establish a register for the long term surveillance of adverse events in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds.

A Silman, L Klareskog, F Breedveld, B Bresnihan, R Maini, P Van Riel, D Symmons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10834856      PMCID： PMC1753170          DOI： 10.1136/ard.59.6.419

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

Review 1.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Richard W Lee; David P D'Cruz
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  The importance of rheumatology biologic registries in Latin America.

Authors:  Maria de la Vega; Hellen M da Silveira de Carvalho; Lucio Ventura Ríos; Maria V Goycochea Robles; Gustavo C Casado
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

4.  Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.

Authors:  Glenn Haugeberg; Inger Johanne Widding Hansen; Dag Magnar Soldal; Tuulikki Sokka
Journal:  Arthritis Res Ther       Date:  2015-08-20       Impact factor: 5.156

5.  Red Cell Distribution Width in Rheumatoid arthritis.

Authors:  Ziad S Al-Rawi; Faiq I Gorial; Anmar Abdulwahhab Al-Bayati
Journal:  Mediterr J Rheumatol       Date:  2018-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.